1. ICH Q8R2 Pharmaceutical Development. Geneva, Switzerland, International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. 2009.
http://www.ich.org/LOB/media/MEDIA4986.pdf
.
2. Food and Drug Administration. Guidance for industry. PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. Rockville: US Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research; 2004.
3. Food and Drug Administration. Pharmaceutical quality for the 21st century: a risk-based approach. Rockville: FDA; 2002.
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm128080.htm
.
4. Yu LX, Raw A, Lionberger R, Rajagopalan R, Lee L, Holcombe F, et al. U.S. FDA question-based review for generic drugs: a new pharmaceutical quality assessment system. J Gen Med. 2007;4:239–48.
5. Yu LX. Pharmaceutical quality by design: product and process development, understanding and control. Pharm Res. 2007;25(4):781–91.